Resveratrol restored Nrf2 function, reduced renal inflammation, and mitigated hypertension in spontaneously hypertensive rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 308, Issue 10, 2015, Pages R840-R846

  Javkhedkar, Apurva A ^a   Quiroz, Yasmir ^b   Rodriguez Iturbe, Bernardo ^b   Vaziri, Nosratola D ^c   Lokhandwala, Mustafa F ^a   Banday, Anees A ^a  

^a UNIVERSITY OF HOUSTON   (United States)

^b HOSPITAL UNIVERSITARIO DE MARACAIBO   (Venezuela)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hypertension; Oxidative stress; Proximal tubules

Indexed keywords

8 ISOPROSTANE; DRINKING WATER; GLUTATHIONE TRANSFERASE; RESVERATROL; TRANSCRIPTION FACTOR NRF2; ANTIOXIDANT; NFE2L2 PROTEIN, RAT; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; GLOMERULOSCLEROSIS; HYPERTENSION; IMMUNOHISTOLOGY; INFLAMMATORY CELL; KIDNEY TUBULE DAMAGE; MALE; NEPHRITIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT; ANIMAL; BLOOD PRESSURE; BODY WEIGHT; DRINKING; DRUG EFFECTS; EATING; INFLAMMATION; KIDNEY; METABOLISM;

ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; BODY WEIGHT; DRINKING; EATING; HYPERTENSION; INFLAMMATION; KIDNEY; MALE; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; STILBENES;

EID: 84930885516     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00308.2014     Document Type: Article

References (35)

1. Banday AA, Fazili FR, Marwaha A, Lokhandwala MF. Mitogenactivated protein kinase upregulation reduces renal D1 receptor affinity and G-protein coupling in obese rats. Kidney Int 71: 397-406, 2007.
2. Banday AA, Marwaha A, Tallam LS, Lokhandwala MF. Tempol reduces oxidative stress, improves insulin sensitivity, decreases renal dopamine D1 receptor hyperphosphorylation, and restores D1 receptor-Gprotein coupling and function in obese Zucker rats. Diabetes 54: 2219-2226, 2005.
3. Behbahani J, Thandapilly SJ, Louis XL, Huang Y, Shao Z, Kopilas MA, Wojciechowski P, Netticadan T, Anderson HD. Resveratrol and small artery compliance and remodeling in the spontaneously hypertensive rat. Am J Hypertens 23: 1273-1278, 2010.
4. Bhatt SR, Lokhandwala MF, Banday AA. Resveratrol prevents endothelial nitric oxide synthase uncoupling and attenuates development of hypertension in spontaneously hypertensive rats. Eur J Pharmacol 667: 258-264, 2011.
5. Biala A, Tauriainen E, Siltanen A, Shi J, Merasto S, Louhelainen M, Martonen E, Finckenberg P, Muller DN, Mervaala E. Resveratrol induces mitochondrial biogenesis and ameliorates ANG II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes. Blood Press 19: 196-205, 2010.
6. Chan V, Fenning A, Iyer A, Hoey A, Brown L. Resveratrol improves cardiovascular function in DOCA-salt hypertensive rats. Curr Pharm Biotechnol 12: 429-436, 2011.
7. Csiszar A, Labinskyy N, Olson S, Pinto JT, Gupte S, Wu JM, Hu F, Ballabh P, Podlutsky A, Losonczy G, de Cabo R, Mathew R, Wolin MS, Ungvari Z. Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats. Hypertension 54: 668-675, 2009.
8. Franco M, Martinez F, Quiroz Y, Galicia O, Bautista R, Johnson RJ, Rodriguez-Iturbe B. Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol 293: R251-R256, 2007.
9. Franco M, Tapia E, Bautista R, Pacheco U, Santamaria J, Quiroz Y, Johnson RJ, Rodriguez-Iturbe B. Impaired pressure natriuresis resulting in salt-sensitive hypertension is caused by tubulointerstitial immune cell infiltration in the kidney. Am J Physiol Renal Physiol 304: F982-F990, 2013.
10. George L, Lokhandwala MF, Asghar M. Exercise activates redoxsensitive transcription factors and restores renal D1 receptor function in old rats. Am J Physiol Renal Physiol 297: F1174-F1180, 2009.
11. Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Weyand CM. Inflammation, immunity, and hypertension. Hypertension 57: 132-140, 2011.
12. Inanaga K, Ichiki T, Matsuura H, Miyazaki R, Hashimoto T, Takeda K, Sunagawa K. Resveratrol attenuates angiotensin II-induced interleukin-6 expression and perivascular fibrosis. Hypertens Res 32: 466-471, 2009.
13. Kobayashi A, Kang MI, Watai Y, Tong KI, Shibata T, Uchida K, Yamamoto M. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol Cell Biol 26: 221-229, 2006.
14. Kumar A, Sharma SS. NF-_B inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy. Biochem Biophys Res Commun 394: 360-365, 2010.
15. Mattson MP, Son TG, Camandola S. Mechanisms of action and therapeutic potential of neurohormetic phytochemicals. Dose Response 5: 174-186, 2007.
16. Miatello R, Vazquez M, Renna N, Cruzado M, Zumino AP, Risler N. Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats. Am J Hypertens 18: 864-870, 2005.
17. Palsamy P, Subramanian S. Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic -cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats. J Cell Physiol 224: 423-432, 2010.
18. Rahman I, Ungvari Z. Resveratrol and Longevity. In: Resveratrol— 2014. Proceedings of the 3rd International Conference on Resveratrol and Health. www.Resveratrol2014.hawaii-conference.com.
19. Rivera L, Moron R, Zarzuelo A, Galisteo M. Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 77: 1053-1063, 2009.
20. Rodriguez-Iturbe B, Franco M, Tapia E, Quiroz Y, Johnson RJ. Renal inflammation, autoimmunity and salt-sensitive hypertension. Clin Exp Pharmacol Physiol 39: 96-103, 2012.
21. Rodriguez-Iturbe B, Johnson RJ. The role of renal microvascular disease and interstitial inflammation in salt-sensitive hypertension. Hypertens Res 33: 975-980, 2010.
22. Rodriguez-Iturbe B, Quiroz Y, Nava M, Bonet L, Chavez M, Herrera-Acosta J, Johnson RJ, Pons HA. Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol 282: F191-F201, 2002.
23. Rodriguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ. Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol 286: F606-F616, 2004.
24. Rodriguez-Iturbe B, Zhan CD, Quiroz Y, Sindhu RK, Vaziri ND. Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 41: 341-346, 2003.
25. Schiffrin EL. T lymphocytes: a role in hypertension? Curr Opin Nephrol Hypertens 19: 181-186, 2010.
26. Sharma S, Chopra K, Kulkarni SK. Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-. Phytother Res 21: 278-283, 2007.
27. Subramanian M, Balasubramanian P, Garver H, Northcott C, Zhao H, Haywood JR, Fink GD, MohanKumar SM, MohanKumar PS. Chronic estradiol-17 exposure increases superoxide production in the rostral ventrolateral medulla and causes hypertension: reversal by resveratrol. Am J Physiol Regul Integr Comp Physiol 300: R1560-R1568, 2011.
28. Thandapilly SJ, Wojciechowski P, Behbahani J, Louis XL, Yu L, Juric D, Kopilas MA, Anderson HD, Netticadan T. Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure. Am J Hypertens 23: 192-196, 2010.
29. Ungvari Z, Bagi Z, Feher A, Recchia FA, Sonntag WE, Pearson K, de Cabo R, Csiszar A. Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2. Am J Physiol Heart Circ Physiol 299: H18-H24, 2010.
30. Vang O, Ahmad N, Baile CA, Baur JA, Brown K, Csiszar A, Das DK, Delmas D, Gottfried C, Lin HY, Ma QY, Mukhopadhyay P, Nalini N, Pezzuto JM, Richard T, Shukla Y, Surh YJ, Szekeres T, Szkudelski T, Walle T, Wu JM. What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS One 6: e19881, 2011.
31. Vaziri ND, Rodriguez-Iturbe B. Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension. Nat Clin Pract Nephrol 2: 582-593, 2006.
32. Wakabayashi N, Slocum SL, Skoko JJ, Shin S, Kensler TW. When NRF2 talks, who’s listening? Antioxid Redox Signal 13: 1649-1663, 2010.
33. Wang Z, Gidwani V, Sun Z, Zhang D, Wong PK. Development of a molecular assay for rapid screening of chemopreventive compounds targeting Nrf2. J Assoc Lab Autom 13: 243-248, 2008.
34. Wang Z, Gidwani V, Zhang DD, Wong PK. Separation-free detection of nuclear factor-_B with double-stranded molecular probes. The Analyst 133: 998-1000, 2008.
35. Zhang H, Morgan B, Potter BJ, Ma L, Dellsperger KC, Ungvari Z, Zhang C. Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging. Am J Physiol Heart Circ Physiol 299: H985-H994, 2010